CASEY COX: Open Payments
NPI 1952662447 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 41 payments from 17 companies in 2025. Trend: 2023 $16 · 2024 $1,251 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $201 |
| PFIZER INC. | 6 | $112 |
| Novo Nordisk Inc | 4 | $71 |
| Exact Sciences Corporation | 3 | $54 |
| Dexcom, Inc. | 2 | $43 |
| Saluda Medical Americas, Inc. | 1 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| ABBVIE INC. | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: TRELEGY ELLIPTA, SHINGRIX, ELIQUIS, Dexcom G6 Transmitter, Evoke, Veozah, Rybelsus, Ozempic.
Industry payments across LA — which companies pay providers there.
